Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 22.8.2019Mylan IRE Healthcare Limited (MYR)59505LIPANTHYL SUPRA 160 mg (tbl flm 90x160 mg (blis.PVC/PE/PVDC/Al))28.8.2019R
 22.8.2019Boehringer Ingelheim International GmbH (BOE)4304BSpiolto Respimat 2,5 mikrogramu/2,5 mikrogramu inhalačný roztok (sol ihl 1x(1 inh.+1 náplň/60 vstrekov-povolenie uvádzať na trh končí dňa 15.11.2019))15.11.2019Z
 22.8.2019Boehringer Ingelheim International GmbH (BOE)44379Spiriva Respimat (sol inh 1x(1 inh.+1 náplň/60 vstrekov-povolenie uvádzať na trh končí dňa 15.11.2019))15.11.2019Z
 22.8.2019Boehringer Ingelheim International GmbH (BOE)7576AStriverdi Respimat (sol ihl 1x(1 inh.+1 náplň/60 vstrekov-povolenie uvádzať na trh končí dňa 15.11.2019))15.11.2019Z
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)04619Atoris 30 (tbl flm 30x30 mg (blis.OPA/Al/PVC/Al))9.9.2019R
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)43362Nolpaza 40 mg (tbl ent 100x40 mg (blis.OPA/Al/PVC/Al))26.8.2019O
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)45737Zalasta 10 mg tablety (tbl 70x10 mg)23.9.2019R
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)5309AMarixino 20 mg filmom obalené tablety (tbl flm 84x20 mg (blis.PVC/PVDC/Al))26.8.2019O
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)76511Nimvastid (tbl oro 28x1x3 mg (blis.OPA/Al/PVC/PET/Al))23.9.2019R
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)8137ASobycor 2,5 mg filmom obalené tablety (tbl flm 30x2,5 mg (blis.Al/Al))2.9.2019O
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)8157ASobycor 10 mg filmom obalené tablety (tbl flm 30x10 mg (blis.Al/Al))26.8.2019O
 22.8.2019KRKA, d.d., Novo mesto (KRK-2)89662Nolpaza 40 mg prášok na injekčný roztok (plv ino 5x40 mg (liek.inj.skl.))16.9.2019R
 21.8.2019GlaxoSmithKline Trading Services Limited (GAG-IRL-3)10193Augmentin SR (tbl plg 28x1 g/62,5 mg (blis.PVC/Al/PA))20.8.2019O
 21.8.2019GlaxoSmithKline Trading Services Limited (GAG-IRL-3)62239Zinnat 125 mg/5 ml (gru por 1x100 ml (liek.skl.tmavá))20.8.2019O
 20.8.2019Glenmark Pharmaceuticals s.r.o. (GLM-CZ)50826Topimark 100 mg (tbl flm 60x100 mg (blis.Al/Al))16.7.2019O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)